1 year ago
Trump Administration Cuts Moderna Funding for Bird Flu Vaccine
The Trump administration canceled $766 million in funding to Moderna for a bird flu vaccine.
This vaccine uses the same technology as the COVID-19 vaccines.
The withdrawal came amid concerns over the vaccine's effectiveness and growing skepticism towards mRNA vaccines.
Moderna's vaccine, mRNA-1018, showed positive early results.
The decision occurs as bird flu spreads in the US, affecting poultry and cattle.
Health officials monitor the situation due to potential human risks.
The Trump administration withdrew $766 million in funding from Moderna.
The funding was for developing an H5N1 vaccine against bird flu.
The decision occurred as bird flu cases surged in the US.
Moderna's vaccine, mRNA-1018, uses mRNA technology, showing promising interim results.
Health Secretary Robert F. Kennedy Jr. questioned the safety of mRNA vaccines.
- Who
- Trump administration and Moderna
- What
- The Trump administration cut $766 million in funding to Moderna for vaccine development.
- Where
- United States
- When
- July 2024 and January 2025 (awarded), May 2025 (withdrawn)
- Why
- The reason for the funding withdrawal is not explicitly stated, although skepticism toward mRNA vaccines is a factor.
Pro-Vaccine Advocates
Skeptics of mRNA Vaccines
Vaccine Safety and Public Health
Pro-Vaccine Advocates
Real-world evidence shows mRNA vaccines are safe and effective.
Skeptics of mRNA Vaccines
The Health Secretary expressed deep skepticism regarding mRNA vaccines.
Key facts
- Company
- Moderna
- Funding Cut
- $766 million
- Vaccine Target
- Bird flu and potential pandemic strains
- Vaccine Name
- mRNA-1018
- Infected Animals
- Hundreds of animals in at least 17 states
